Kim Sablich
2020 - Jazz Pharmaceuticals
Compensation breakdown
| Bonus | $300,000 |
|---|---|
| Non-Equity Incentive Plan | $235,000 |
| Option Awards | $1,616,987 |
| Salary | $327,885 |
| Stock Awards | $2,134,774 |
| Other | $6,598 |
| Total | $4,621,245 |
Sablich received $2.1M in stock awards, accounting for 46% of the total pay in 2020.
Sablich also received $300K in bonus, $235K in non-equity incentive plan, $1.6M in option awards, $327.9K in salary and $6.6K in other compensation.
Rankings
In 2020, Kim Sablich's compensation ranked 2,426th out of 13,090 executives tracked by ExecPay. In other words, Sablich earned more than 81.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,426 out of 13,090 | 82nd |
Division Manufacturing | 929 out of 5,620 | 84th |
Major group Chemicals And Allied Products | 329 out of 2,253 | 85th |
Industry group Drugs | 280 out of 1,953 | 86th |
Industry Pharmaceutical Preparations | 202 out of 1,458 | 86th |
Pay ratio
| Kim Sablich's Pay | $4,621,245 |
|---|---|
| Median Employee's Pay | $234,935 |
| Pay Ratio | 20to 1 |
In 2020, the annual total compensation of Kim Sablich was $4,621,245.
The annual total compensation of the median employee at Jazz Pharmaceuticals was $234,935.
The ratio of Kim Sablich's pay to the pay of median employee was therefore 20 to one.
Sablich's colleagues
We found five more compensation records of executives who worked with Kim Sablich at Jazz Pharmaceuticals in 2020.
2020
Bruce Cozadd
Jazz Pharmaceuticals
Chief Executive Officer
2020
Daniel Swisher
Jazz Pharmaceuticals
Chief Operating Officer
2020
Renée Gal
Jazz Pharmaceuticals
Chief Financial Officer
2020
Robert Ianonne
Jazz Pharmaceuticals
Chief Medical Officer
2020
Robert MSCE
Jazz Pharmaceuticals